Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Phase II Randomized Study of Adaptively Delivered LINAC-Based Stereotactic Radiation for Volatile Brain Metastases With Same-Day Planning and Margin Reduction

NCT07132190 is registered in ClinicalTrials.gov with Ayal A. Aizer, MD as lead sponsor.

NCT NCT07132190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07132190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Phase II Randomized Study of Adaptively Delivered LINAC-Based Stereotactic Radiation for Volatile Brain Metastases With Same-Day Planning and Margin Reduction
Lead sponsor
Ayal A. Aizer, MD
Phase
Phase 2
Overall status
Recruiting
Start date
December 30, 2025
Completion date
September 30, 2029
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases from extra-cranial solid tumors, brain metastases from non-small cell lung cancer (nsclc), brain metastases, adult, brain tumor - metastatic